Enovis to Participate in Upcoming Investor Conferences
Wilmington, DE, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:
- Canaccord Genuity 44th Annual Growth Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Tuesday, August 13th at 2:00 p.m. Eastern Time.
- Wells Fargo Healthcare Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Thursday, September 5th at 11:00 a.m. Eastern Time.
- Baird 2024 Global Healthcare Conference: Matt Trerotola, Chair, and Chief Executive Officer, will participate in a fireside chat on Wednesday, September 11th at 12:50 p.m. Eastern Time.
A link to the live audio webcasts, as well as a replay of these events, will be available on the Company’s website under the Investors tab at Events and Presentations.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit .
Contact:
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
